Fluorodeoxyglucose Positron Emission Tomography in the Presence of Cardiac Metastases
| Autor: | Richard F. Little, John D. Nguyen, Jorge A. Carrasquillo, Clara C. Chen, Qin C. Ryan, Wyndham H. Wilson |
|---|---|
| Rok vydání: | 2003 |
| Předmět: |
Male
medicine.medical_specialty Whole-Body Counting Diagnosis Differential Heart Neoplasms Fluorodeoxyglucose positron emission tomography Lesion Fluorodeoxyglucose F18 Humans Medicine Radiology Nuclear Medicine and imaging In patient Melanoma Neoplasm Staging Fluorodeoxyglucose Incidental Findings medicine.diagnostic_test business.industry Lymphoma Non-Hodgkin General Medicine Middle Aged Underlying disease Positron emission tomography Radiology Radiopharmaceuticals medicine.symptom business Nuclear medicine Preclinical imaging Disease staging Tomography Emission-Computed medicine.drug |
| Zdroj: | Clinical Nuclear Medicine. 28:979-980 |
| ISSN: | 0363-9762 |
| DOI: | 10.1097/01.rlu.0000099808.30653.06 |
| Popis: | Physiological fluorodeoxyglucose (FDG) uptake can obscure underlying disease or can even falsely suggest disease in patients undergoing whole-body positron emission tomography (PET) scanning for disease staging. Myocardial uptake in particular can present a problem because of its variability in fasting patients. Nonetheless, we present 2 cases in which FDG PET imaging was effective in identifying metastatic disease to the heart. In 1 case, an FDG PET scan revealed previously unsuspected myocardial metastases. In another case, FDG PET was useful in characterizing an intraatrial mass seen on anatomic imaging as a metabolically active lesion. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|